You have 9 free searches left this month | for more free features.

FMISO-PET

Showing 1 - 25 of 4,597

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hypoxia Before Radioembolization Treatment With 18F-FMISO PET

Recruiting
  • Radioembolization
  • +3 more
  • 18F-Fluoromisonidazole PET
  • Ankara, Turkey
    Ankara University
Sep 7, 2023

HER2-positive Breast Cancer Trial in Birmingham ([18F]FMISO PET/MRI imaging)

Recruiting
  • HER2-positive Breast Cancer
  • [18F]FMISO PET/MRI imaging
  • Birmingham, Alabama
    The University of Alabama at Birmingham
Dec 8, 2022

Triple Negative Breast Cancer Trial in Birmingham ([18F]FMISO-PET with contrast-enhanced MRI)

Not yet recruiting
  • Triple Negative Breast Cancer
  • [18F]FMISO-PET with contrast-enhanced MRI
  • Birmingham, Alabama
    UAB
Nov 15, 2022

Brain Cancer Trial in Salt Lake City ([18F]fluoro-2-deoxy-D-glucose (FDG),

Recruiting
  • Brain Cancer
  • [18F]fluoro-2-deoxy-D-glucose (FDG)
  • +3 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jan 3, 2023

Head and Neck Squamous Cell Carcinoma Trial in Delhi (DE-HyART, Standard Arm, Cisplatin injection)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • DE-HyART
  • +3 more
  • Delhi, India
    Rajiv Gandhi Cancer Institute and Research Centre
Oct 20, 2023

Esophageal Cancer Trial in Salt Lake City (Radiation, FMISO PET CT)

Recruiting
  • Esophageal Cancer
  • Radiation
  • FMISO PET CT
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jun 10, 2022

Idiopathic Pulmonary Fibrosis Trial in Dijon (FMISO-PET Protocol)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • FMISO-PET Protocol
  • Dijon, France
    Chu Dijon Bourgogne
Jul 5, 2022

Recurrent Glioblastoma Trial in Boston (FMISO PET, MRI, Bevacizumab)

Completed
  • Recurrent Glioblastoma
  • FMISO PET
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Jul 9, 2021

Head Neck Cancer Trial in United States (fluorine-18-labeled fluoro-misonidazole (18F-FMISO), 18F-FMISO PET scan, MRI)

Active, not recruiting
  • Head and Neck Cancer
  • fluorine-18-labeled fluoro-misonidazole (18F-FMISO)
  • +3 more
  • Basking Ridge, New Jersey
  • +4 more
Jul 8, 2022

Nasopharyngeal Carcinoma Trial in Singapore ((18)F-fluoromisonidazole (FMISO))

Completed
  • Nasopharyngeal Carcinoma
  • (18)F-fluoromisonidazole (FMISO)
  • Singapore, Singapore
  • +1 more
Aug 9, 2021

BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in

Recruiting
  • BCLC Stage A Hepatocellular Carcinoma
  • +3 more
  • 18F-Fluoromisonidazole
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
May 25, 2022

Malignant Brain Tumor Trial in Portland (¹8F-Fluoromisonidazole, Computed Tomography, Magnetic Resonance Imaging)

Recruiting
  • Malignant Brain Neoplasm
  • Portland, Oregon
    OHSU Knight Cancer Institute
Feb 19, 2022

Non-Small-Cell-Lung Cancer (NSCLC) Trial in New York (18F-FMISO, PET/CT)

Active, not recruiting
  • Non-Small-Cell-Lung Cancer (NSCLC)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2022

Soft Tissue Sarcoma Trial in Philadelphia (18F-FMISO)

Terminated
  • Soft Tissue Sarcoma
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Mar 15, 2021

HPV-Associated Oropharyngeal Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Neck Trial in United States (diagnostic

Recruiting
  • HPV-Associated Oropharyngeal Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of the Neck
  • F-FMISO PET/CT Scan
  • +5 more
  • Hartford, Connecticut
  • +9 more
Jan 31, 2023

HPV, Throat Cancer, Oropharyngeal Carcinoma Trial in United States (diagnostic test, radiation, drug)

Recruiting
  • HPV
  • +4 more
  • 18 F-FMISO PET/CT
  • +4 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 4, 2022

Head Neck Cancer, Head and Neck Carcinoma, Head and Neck Tumors Trial in United States (diagnostic test, radiation, drug)

Recruiting
  • Head and Neck Cancer
  • +3 more
  • 18F-FMISO PET/CT scan
  • +2 more
  • Basking Ridge, New Jersey
  • +5 more
Sep 15, 2022

Novel Hypoxia Imaging for Head and Neck Cancer: Imaging

Not yet recruiting
  • Head and Neck Cancer
  • +3 more
  • [18F]MISO-PET/CT
  • (no location specified)
Oct 29, 2023

High Grade Glioma Trial in Birmingham (O-(2-[18F]Fluoroethyl)-L-tyrosine, [18F]-FET with PET/MRI)

Not yet recruiting
  • High Grade Glioma
  • O-(2-[18F]Fluoroethyl)-L-tyrosine, [18F]-FET with PET/MRI
  • Birmingham, Alabama
    UAB
Nov 21, 2022

Recurrent Glioblastoma Trial in Philadelphia (biological, drug, radiation)

Terminated
  • Recurrent Glioblastoma
  • [18F]fluoromisonidazole
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Feb 13, 2020

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +24 more
  • 18F-Fluoromisonidazole
  • +4 more
  • La Jolla, California
  • +15 more
Jan 3, 2023

Head and Neck Squamous Cell Carcinoma, Brain Metastases Trial in Nashville (Magnetic Resonance Imaging (MRI), Positron Emission

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Brain Metastases
  • Magnetic Resonance Imaging (MRI)
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 10, 2023

Breast Cancer, Brain Metastases Trial in New York (Brain Imaging with 18F-FES)

Not yet recruiting
  • Breast Cancer
  • Brain Metastases
  • Brain Imaging with 18F-FES
  • New York, New York
    New York-Presbyterian/Weill Cornell Medical Center
Oct 2, 2023

Stage III Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell

Active, not recruiting
  • Stage III Lung Non-Small Cell Cancer AJCC v7
  • +2 more
  • Palo Alto, California
  • +30 more
Apr 28, 2021

Head Neck Cancer Trial in New York (PET/CT Imaging)

Withdrawn
  • Head and Neck Cancer
  • PET/CT Imaging
  • New York, New York
    Citigroup Biomedical Imaging Center
Dec 21, 2021